000302283 001__ 302283
000302283 005__ 20250731092439.0
000302283 0247_ $$2doi$$a10.1038/s41684-025-01573-w
000302283 0247_ $$2pmid$$apmid:40571749
000302283 0247_ $$2ISSN$$a0093-7355
000302283 0247_ $$2ISSN$$a1548-4475
000302283 0247_ $$2altmetric$$aaltmetric:178400128
000302283 037__ $$aDKFZ-2025-01302
000302283 041__ $$aEnglish
000302283 082__ $$a630
000302283 1001_ $$0P:(DE-HGF)0$$aSeib, Jessica$$b0$$eFirst author
000302283 245__ $$aMurine astrovirus infection course and antibody response in different mouse strains.
000302283 260__ $$aNew York, NY$$bNature Publ. Co.$$c2025
000302283 3367_ $$2DRIVER$$aarticle
000302283 3367_ $$2DataCite$$aOutput Types/Journal article
000302283 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1753946645_19396
000302283 3367_ $$2BibTeX$$aARTICLE
000302283 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000302283 3367_ $$00$$2EndNote$$aJournal Article
000302283 500__ $$a#EA:W440#LA:W440# / 54, pages 178–187 (2025)
000302283 520__ $$aMonitoring the health of mice used in animal experiments constitutes an important instrument toward microbiological standardization, as infections can alter physiological parameters and immune reactions and may therefore have an essential impact on experimental outcome. In view of the high prevalence rates of murine astrovirus (MuAstV) infections in laboratory mouse facilities worldwide and the potential impact on research outcomes and reproducibility, there is a need to include MuAstV in the existing laboratory mice health monitoring programs. Here, to determine the sentinel strain and diagnostic method of choice, we aimed to assess the course of MuAstV infection and the resulting immune response in three immunocompetent mouse strains (Crl:CD1 (ICR), C57BL/6J and BALB/cOlaHsd) and one immunodeficient strain (NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ) by analyzing blood, feces and tissue samples with MuAstV-specific polymerase chain reaction and serology. Depending on the mouse strain, the duration of infection and viral load differed significantly, as well as the rapidity and quantity of antibody production. Virus shedding in immunocompetent mice was limited to a maximum of 4 weeks, whereas immunodeficient mice shed virus for the entire duration of this study. A fast antibody response with high titers was found only in outbred CD1 mice. In C57BL/6J and BALB/c mice, however, seropositivity and high antibody levels were reached only after the second infection. These results not only improve our understanding of the infection characteristics of MuAstV, presumably the most prevalent virus in laboratory mice, but also help to set up a health monitoring routine giving meaningful and reliable results on the MuAstV infection status of laboratory mouse populations.
000302283 536__ $$0G:(DE-HGF)POF4-314$$a314 - Immunologie und Krebs (POF4-314)$$cPOF4-314$$fPOF IV$$x0
000302283 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000302283 7001_ $$0P:(DE-He78)3b05a05c74fcfafec06747c40ac929c0$$aHöfler, Daniela$$b1$$udkfz
000302283 7001_ $$0P:(DE-He78)03e697eff41037b4a1f95aa128292d6c$$aHornetz, Lena$$b2$$udkfz
000302283 7001_ $$0P:(DE-He78)a34cae00e40416f4fdfb486dc0a2f5f0$$aOhl, Nicole$$b3$$udkfz
000302283 7001_ $$0P:(DE-He78)98179c914fa748a4060c13114dd4bfbb$$aGötz, Katrin$$b4$$udkfz
000302283 7001_ $$0P:(DE-He78)9029e7d8e1a0081844702984bb4a06be$$aVogel, Klaus$$b5$$udkfz
000302283 7001_ $$0P:(DE-He78)31d7c3e829be03400641f80b821ef728$$aButt, Julia$$b6$$udkfz
000302283 7001_ $$0P:(DE-He78)4e5ebf211bad5a927f9a00c8e9c1d116$$aSchmidt, Katja$$b7$$eLast author$$udkfz
000302283 773__ $$0PERI:(DE-600)2822788-8$$a10.1038/s41684-025-01573-w$$p178–187 $$tLab animal$$v54$$x0093-7355$$y2025
000302283 909CO $$ooai:inrepo02.dkfz.de:302283$$pVDB
000302283 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000302283 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)3b05a05c74fcfafec06747c40ac929c0$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000302283 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)03e697eff41037b4a1f95aa128292d6c$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000302283 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a34cae00e40416f4fdfb486dc0a2f5f0$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000302283 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)98179c914fa748a4060c13114dd4bfbb$$aDeutsches Krebsforschungszentrum$$b4$$kDKFZ
000302283 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)9029e7d8e1a0081844702984bb4a06be$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000302283 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)31d7c3e829be03400641f80b821ef728$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000302283 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4e5ebf211bad5a927f9a00c8e9c1d116$$aDeutsches Krebsforschungszentrum$$b7$$kDKFZ
000302283 9131_ $$0G:(DE-HGF)POF4-314$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImmunologie und Krebs$$x0
000302283 9141_ $$y2025
000302283 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2024-12-14$$wger
000302283 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bLAB ANIMAL : 2022$$d2024-12-14
000302283 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-14
000302283 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-14
000302283 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-14
000302283 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-14
000302283 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-14
000302283 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-14
000302283 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bLAB ANIMAL : 2022$$d2024-12-14
000302283 9202_ $$0I:(DE-He78)W440-20160331$$kW440$$lMikrobiologische Diagnostik$$x0
000302283 9201_ $$0I:(DE-He78)W440-20160331$$kW440$$lMikrobiologische Diagnostik$$x0
000302283 9201_ $$0I:(DE-He78)D320-20160331$$kD320$$lInfektionen und Krebs-Epidemiologie$$x1
000302283 9201_ $$0I:(DE-He78)W410-20160331$$kW410$$lZentrum für Präklinische Forschung$$x2
000302283 9200_ $$0I:(DE-He78)W440-20160331$$kW440$$lMikrobiologische Diagnostik$$x0
000302283 980__ $$ajournal
000302283 980__ $$aVDB
000302283 980__ $$aI:(DE-He78)W440-20160331
000302283 980__ $$aI:(DE-He78)D320-20160331
000302283 980__ $$aI:(DE-He78)W410-20160331
000302283 980__ $$aUNRESTRICTED